1. Home
  2. GHRS vs TTI Comparison

GHRS vs TTI Comparison

Compare GHRS & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • TTI
  • Stock Information
  • Founded
  • GHRS 2018
  • TTI 1981
  • Country
  • GHRS Ireland
  • TTI United States
  • Employees
  • GHRS N/A
  • TTI N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • TTI Oil & Gas Production
  • Sector
  • GHRS Health Care
  • TTI Energy
  • Exchange
  • GHRS Nasdaq
  • TTI Nasdaq
  • Market Cap
  • GHRS 583.1M
  • TTI 467.4M
  • IPO Year
  • GHRS 2021
  • TTI 1990
  • Fundamental
  • Price
  • GHRS $10.60
  • TTI $2.97
  • Analyst Decision
  • GHRS Strong Buy
  • TTI Strong Buy
  • Analyst Count
  • GHRS 8
  • TTI 3
  • Target Price
  • GHRS $30.63
  • TTI $6.17
  • AVG Volume (30 Days)
  • GHRS 146.4K
  • TTI 1.7M
  • Earning Date
  • GHRS 05-08-2025
  • TTI 04-29-2025
  • Dividend Yield
  • GHRS N/A
  • TTI N/A
  • EPS Growth
  • GHRS N/A
  • TTI 426.72
  • EPS
  • GHRS N/A
  • TTI 0.84
  • Revenue
  • GHRS N/A
  • TTI $605,279,000.00
  • Revenue This Year
  • GHRS N/A
  • TTI $8.58
  • Revenue Next Year
  • GHRS N/A
  • TTI $10.67
  • P/E Ratio
  • GHRS N/A
  • TTI $3.53
  • Revenue Growth
  • GHRS N/A
  • TTI N/A
  • 52 Week Low
  • GHRS $6.00
  • TTI $2.03
  • 52 Week High
  • GHRS $20.50
  • TTI $5.12
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 59.36
  • TTI 56.86
  • Support Level
  • GHRS $9.81
  • TTI $2.60
  • Resistance Level
  • GHRS $11.50
  • TTI $3.06
  • Average True Range (ATR)
  • GHRS 0.72
  • TTI 0.17
  • MACD
  • GHRS 0.23
  • TTI 0.08
  • Stochastic Oscillator
  • GHRS 89.60
  • TTI 82.47

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.

Share on Social Networks: